These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28963907)

  • 1. Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease.
    Guerrero-Garcia TA; Mogollon RJ; Castillo JJ
    Leuk Res; 2017 Nov; 62():12-16. PubMed ID: 28963907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating Bortezomib in the Management of Plasmablastic Lymphoma.
    Umeanaeto O; Gamboa J; Diaz J; Hakim MN; Corral J; Philipovskiy A; Gaur S
    Anticancer Res; 2019 Sep; 39(9):5003-5007. PubMed ID: 31519607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.
    Sabry W; Wu Y; Kodad SG
    Curr Oncol; 2022 Jul; 29(7):5042-5053. PubMed ID: 35877259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term complete remission of HIV-negative primary testicular plasmablastic lymphoma treated with bortezomib in combination with EPOCH].
    Fujishima T; Kawabata Y; Michishita Y; Kitabayashi A; Takahashi N
    Rinsho Ketsueki; 2022; 63(10):1386-1391. PubMed ID: 36351644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide.
    Cheng L; Song Q; Liu M; Wang Y; Yi H; Qian Y; Xu P; Cheng S; Wang C; Wang L; Zhao W
    Front Immunol; 2021; 12():702593. PubMed ID: 34322131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Use of Bortezomib-Lenalidomide Combination as Treatment for a Patient With Plasmablastic Lymphoma.
    Marrero WD; Cruz-Chacón A; Castillo C; Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):e275-e277. PubMed ID: 29753690
    [No Abstract]   [Full Text] [Related]  

  • 7. Bortezomib- and Lenalidomide-Based Treatment of Refractory Plasmablastic Lymphoma.
    Ando K; Imaizumi Y; Kobayashi Y; Niino D; Hourai M; Sato S; Sawayama Y; Hata T; Ohshima K; Miyazaki Y
    Oncol Res Treat; 2020; 43(3):112-116. PubMed ID: 31842017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
    Pretscher D; Kalisch A; Wilhelm M; Birkmann J
    Ann Hematol; 2017 Jun; 96(6):967-970. PubMed ID: 28011983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib in plasmablastic lymphoma: a case report and review of the literature.
    Saba NS; Dang D; Saba J; Cao C; Janbain M; Maalouf B; Safah H
    Onkologie; 2013; 36(5):287-91. PubMed ID: 23689224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular Plasmablastic Lymphoma in an HIV-Negative Patient: A Rare Case Presentation.
    Nwanwene K; Khan NAJ; Alsharedi M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211017423. PubMed ID: 34032157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral plasmablastic lymphoma: A case report.
    Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
    Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma.
    Akce M; Chang E; Haeri M; Perez M; Finch CJ; Udden MM; Mims MP
    Case Rep Hematol; 2016; 2016():3598547. PubMed ID: 27957358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
    Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
    J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV-negative plasmablastic lymphoma attaining sustained remission with bortezomib-combined dose-adjusted EPOCH therapy].
    Kobayashi H; Miyagi N
    Rinsho Ketsueki; 2017; 58(5):443-448. PubMed ID: 28592757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].
    Han X; Hu LX; Ouyang MQ; Duan MH; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):290-294. PubMed ID: 28468089
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
    Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib.
    Cencini E; Fabbri A; Guerrini S; Mazzei MA; Rossi V; Bocchia M
    Eur J Haematol; 2016 Jun; 96(6):650-654. PubMed ID: 26715026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
    Fedele PL; Gregory GP; Gilbertson M; Shortt J; Kumar B; Opat S; Grigoriadis G
    Ann Hematol; 2016 Mar; 95(4):667-8. PubMed ID: 26801792
    [No Abstract]   [Full Text] [Related]  

  • 20. Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.
    Lin L; Zhang X; Dong M; Li L; Wang X; Zhang L; Fu X; Sun Z; Wu J; Li Z; Chang Y; Wang Y; Zhou Z; Zhang M; Chen Q
    Medicine (Baltimore); 2017 Feb; 96(7):e6171. PubMed ID: 28207555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.